Brought to you by 
J&J buys Inverness diabetes products business
28 Nov 2001
Executive Summary
Johnson & Johnson has acquired the diabetes self-management business of Inverness Medical Technology in a stock swap. Inverness will spin off its lesser lines--women's health, nutritional supplements, plus technology for diagnostics applications outside diabetes--into a separately traded public company to be owned by Inverness shareholders.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Glucose Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J buys Inverness diabetes products business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice